Hurlburt Elizabeth 4

Accession 0000899140-24-001286

CIK 0001410098other

View on SEC.gov Company Profile

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 8:37 PM ET

Size

27.7 KB

Accession

0000899140-24-001286

Insider Transaction Report

Form 4

Period: 2024-11-14

CorMedix Inc.CRMD

Hurlburt Elizabeth

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock
2024-11-14$1.45/sh+3$4→ 45,400 total
Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2024-11-14−25,000→ 75,000 total
Exercise: $3.47Exp: 2034-01-11→ Common Stock (25,000 underlying)
Exercise/Conversion
Common Stock
2024-11-14$8.30/sh+8,169$67,803→ 53,569 total
Exercise/Conversion
Common Stock
2024-11-14$4.08/sh+34,467$140,625→ 97,924 total
Sale
Common Stock
2024-11-14$11.18/sh−140,027$1,565,670→ 45,397 total
Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2024-11-14−62,500→ 62,500 total
Exercise: $4.43Exp: 2033-01-14→ Common Stock (62,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2024-11-14−8,169→ 12,711 total
Exercise: $8.30Exp: 2029-01-10→ Common Stock (8,169 underlying)
Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2024-11-14−9,888→ 27,612 total
Exercise: $5.63Exp: 2030-05-11→ Common Stock (9,888 underlying)
Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2024-11-14−34,467→ 3,033 total
Exercise: $4.08Exp: 2030-05-11→ Common Stock (34,467 underlying)
Exercise/Conversion
Common Stock
2024-11-14$5.63/sh+9,888$55,669→ 63,457 total
Exercise/Conversion
Common Stock
2024-11-14$4.43/sh+62,500$276,875→ 160,424 total
Exercise/Conversion
Common Stock
2024-11-14$3.47/sh+25,000$86,750→ 185,424 total
Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2024-11-14−3→ 53,997 total
Exercise: $1.45Exp: 2028-03-19→ Common Stock (3 underlying)

Footnotes (7)

[F1]This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
[F2]These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones. This option was previously reported as covering 186,000 shares but was adjusted to reflect a reverse stock split that occurred on March 26, 2019.
[F3]These options were granted 1/10/2019 and vested as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones.
[F4]These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
[F5]These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
[F6]These options were granted on 1/14/2023. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant and will vest 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
[F7]These options were granted on 01/12/2024. These options vested 1/4 on the date of grant, and, subject to continued employment, will vest 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Documents

1 file

4
form4.xmlPrimary

Issuer

CorMedix Inc.

CIK 0001410098

→

Entity typeother

Related Parties

filerCIK 0001735256

Filing Metadata

Form type: 4
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 8:37 PM ET
Size: 27.7 KB

View on SEC.gov